PHGDH and breast carcinoma: Interestingly, pharmacologically or shRNA targeting PHGDH showed decreased proliferation rates in OS cell lines, but no effects were shown in breast cancer cell lines with low PHGDH expression, thus confirming a potential therapeutic interest.